Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry ...

Improperly issued drug patents can and do delay the entry of generic drugs. Indeed, a key strategy of brand-name pharmaceutical manufacturers is to obtain patents not just for active ingredients, but ...

Internet postal provider Stamps.com (Nasdaq: STMP) announced Monday that it has acquired the domain name, URL and various patents from former competitor E-Stamp for US$7.5 mission. “These acquisitions ...

Microsoft's contentious patent describing the mechanism used to store long filenames on FAT filesystems without breaking compatibility with old applications has been upheld by the German appeal court ...

Microsoft Corp. said Tuesday that its patents on technology for saving computer files with familiar names had been upheld after a lengthy challenge. David Kaefer, a director of business development ...

A brand-name pharmaceutical company engaged in patent litigation with a generic competitor settles the dispute by paying the generic competitor a significant sum of money to drop the litigation and ...

Between now and October 2012, the patents for seven big name drugs will expire, including those for a popular cholesterol lowering drug, Lipitor, and the blood thinner Plavix. In addition, the next ...

“We are working on a bipartisan basis to craft legislation to address this problem of abusive practices and restore confidence in the American patent system.” These bold words, from the pens of ...